Developments and current pharmacotherapeutic recommendations for ankylosing spondylitis

Expert Opinion on Pharmacotherapy
J Zochling, Jürgen Braun

Abstract

The introduction of anti-TNFalpha therapy into the field of rheumatology has led to dramatic improvements in patient care, perhaps the most remarkable being in the management of ankylosing spondylitis. As experience with these compounds grows, their place in therapeutic strategy is becoming clearer, and it has been possible to develop evidence- and expertise-based recommendations for the management of ankylosing spondylitis to aid the clinician in patient care. This review outlines treatment advances in ankylosing spondylitis, including the use of anti-TNFalpha agents, and how these have been incorporated into clinical recommendations for daily use.

References

Jan 1, 1976·Rheumatology and Rehabilitation·J D Jessop
Dec 1, 1992·Arthritis and Rheumatism·L D CarboneL J Melton
Mar 3, 1990·BMJ : British Medical Journal·S H RalstonR D Sturrock
Jan 1, 1990·Current Medical Research and Opinion·A C SchwarzerP M Brooks
May 1, 1981·Arthritis and Rheumatism·G MintzG Gutiérrez
Jan 1, 1994·Scandinavian Journal of Rheumatology·M DougadosC Gomeni
Feb 1, 1994·Annals of the Rheumatic Diseases·S DonnellyT D Spector
Jan 20, 1998·Arthritis and Rheumatism·J BraunJ Sieper
Feb 26, 2000·Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association·M M Ward
Dec 1, 2001·Scandinavian Journal of Rheumatology·L AltanM Yurtkuran
May 3, 2002·The New England Journal of Medicine·Jennifer D GormanJohn C Davis
Jul 13, 2002·Arthritis and Rheumatism·Feng HuangDavid Tak Yan Yu
Oct 31, 2002·Best Practice & Research. Clinical Rheumatology·J Braun, D van der Heijde
Nov 8, 2002·Rheumatology·B RoychowdhuryR J Moots
Dec 20, 2002·Zeitschrift für Rheumatologie·B Manger, UNKNOWN Kommission Pharmkotherapie, Deutsche Gesellschaft für Rheumatologie
Jul 19, 2003·Rheumatology·H HaibelJ Braun
Nov 13, 2003·Arthritis and Rheumatism·John C DavisUNKNOWN Enbrel Ankylosing Spondylitis Study Group
Mar 31, 2004·Annals of the Rheumatic Diseases·M C W CreemersP L C M van Riel
Apr 15, 2004·Annals of the Rheumatic Diseases·M RudwaleitJ Sieper

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.